Risk Intelligence
Ethanol price stagnation vs rising cane costs
View Risks →Godavari Biorefineries delivered a mixed Q3 FY26 with modest revenue growth of 2.5% YoY to ₹461.9 Cr, but strong profitability improvement as EBITDA grew 13.8% YoY to ₹45.1 Cr and margins expanded 97 bps to 9.8%.
✓ Verified against BSE filing
Godavari Biorefineries delivered a mixed Q3 FY26 with modest revenue growth of 2.5% YoY to ₹461.9 Cr, but strong profitability improvement as EBITDA grew 13.8% YoY to ₹45.1 Cr and margins expanded 97 bps to 9.8%. The bio-based chemicals segment drove margin expansion, with its EBITDA margin improving to 7.7% from 4.5% last year, supported by a higher share of specialty products. Ethanol faced margin pressure due to rising cane costs and unchanged government pricing, but management is mitigating this via multi-feedstock flexibility and ENA sales. The consumer brand Jivana crossed ₹100 Cr revenue in 9M FY26, with distribution reaching 7,500+ outlets. Key risks include further delay in the grain-based distillery commissioning (now expected next quarter) and lack of government ethanol price revision, which could pressure ethanol margins. Management reiterated its target to 3x EBITDA by FY29 through capex of ₹25 Cr, with 75% allocated to bio-based chemicals.
Ethanol price stagnation vs rising cane costs
View Risks →Full transcript text is available on this route.
Read Transcript →Improved from 4.5% in Q3 FY25, driven by higher specialty product share.
Crossed ₹100 Cr milestone in first 9 months, validating B2C strategy.
Expanded from 7,000+ in previous quarter, growing distribution reach.
Declined 48% YoY, reflecting improved cash flows and balance sheet strength.
Management targets tripling EBITDA over 4 years from FY25 base, with capex of ₹25 Cr allocated 75% to bio-based chemicals and 25% to ethanol.
Government has not revised ethanol prices for 2-3 years while cane costs have risen, pressuring ethanol margins.
View Risks →